Success Metrics

Clinical Success Rate
70.0%

Based on 7 completed trials

Completion Rate
70%(7/10)
Active Trials
0(0%)
Results Posted
29%(2 trials)
Terminated
3(25%)

Phase Distribution

Ph early_phase_1
1
8%
Ph phase_4
1
8%
Ph not_applicable
5
42%
Ph phase_2
2
17%
Ph phase_3
2
17%

Phase Distribution

1

Early Stage

2

Mid Stage

3

Late Stage

Phase Distribution11 total trials
Early Phase 1First-in-human
1(9.1%)
Phase 2Efficacy & side effects
2(18.2%)
Phase 3Large-scale testing
2(18.2%)
Phase 4Post-market surveillance
1(9.1%)
N/ANon-phased studies
5(45.5%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

63.6%

7 of 11 finished

Non-Completion Rate

36.4%

4 ended early

Currently Active

0

trials recruiting

Total Trials

12

all time

Status Distribution
Completed(7)
Terminated(4)
Other(1)

Detailed Status

Completed7
Terminated3
unknown1
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
12
Active
0
Success Rate
70.0%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (9.1%)
Phase 22 (18.2%)
Phase 32 (18.2%)
Phase 41 (9.1%)
N/A5 (45.5%)

Trials by Status

unknown18%
withdrawn18%
completed758%
terminated325%

Recent Activity

Clinical Trials (12)

Drug Details

Intervention Type
DEVICE
Total Trials
12